Literature DB >> 3038556

Release and regulation of atrial natriuretic peptide (ANP).

H Ruskoaho, R E Lang, M Toth, D Ganten, T Unger.   

Abstract

Mammalian atrial cardiocytes synthesize and secrete a hormone called atrial natriuretic peptide (ANP), which causes natriuresis, diuresis and inhibition of smooth muscle contraction, aldosterone and renin release. Volume loading, vasoconstrictor agents, immersion in water, atrial tachycardia and high salt diets have been reported to increase the release of cardiac ANP, thereby suggesting that the peptide is released in response to an increase in atrial pressure. That stretch is an important stimulus for ANP release is also suggested by clinical studies demonstrating a direct correlation between secretion rate and atrial pressure. The experiments using isolated perfused rat heart provide direct evidence that distension of the right atrium stimulates the release of ANP. Pharmacological studies in the isolated heart point to roles of cytosolic calcium, the phosphoinositide system and the cyclic AMP pathway in the regulation of ANP release. The concentration of calcium in heart muscle cells, in addition to the length of the muscle fibers, depends on many factors such as the action of humoral substances, cardiac nerve activity and heart rate, which may all contribute to the regulation of ANP secretion.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3038556     DOI: 10.1093/eurheartj/8.suppl_b.99

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  14 in total

1.  The effect of medetomidine, an alpha 2-adrenoceptor agonist, on plasma atrial natriuretic peptide levels, haemodynamics and renal excretory function in spontaneously hypertensive and Wistar-Kyoto rats.

Authors:  H Ruskoaho; J Leppäluoto
Journal:  Br J Pharmacol       Date:  1989-05       Impact factor: 8.739

2.  Cardiac atria are the primary source of ANP release in hypoxia-adapted rats.

Authors:  Brian Casserly; Linda Pietras; Joy Schuyler; Richard Wang; Nicholas S Hill; James R Klinger
Journal:  Life Sci       Date:  2010-08-05       Impact factor: 5.037

3.  Serum atrial natriuretic peptide (ANP) as an objective indicator for the diagnosis of neurogenic shock: animal experiment and human case report.

Authors:  Min-Zhu Zhao; Yong-Guo Li; Peng Zhang; Jin-Cheng Xiong; Shi-Sheng Zhu; Xuan Xiao; Jian-Bo Li
Journal:  Int J Legal Med       Date:  2016-10-10       Impact factor: 2.686

4.  Release of atrial natriuretic peptide from rat myocardium in vitro: effect of minoxidil-induced hypertrophy.

Authors:  P Kinnunen; T Taskinen; J Leppäluoto; H Ruskoaho
Journal:  Br J Pharmacol       Date:  1990-04       Impact factor: 8.739

5.  Atrial natriuretic factor mRNA and binding sites in the adrenal gland.

Authors:  D J Nunez; A P Davenport; M J Brown
Journal:  Biochem J       Date:  1990-10-15       Impact factor: 3.857

6.  Presence of atrial natriuretic factor and cyclic guanosine monophosphate in saliva. Comparison of plasma and salivary concentrations during a head-down tilt.

Authors:  G Gauquelin; A Maillet; A M Allevard; D Vorobiev; A I Grigoriev; C Gharib
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1992

7.  Elevation of plasma atrial natriuretic peptide occurs during adrenaline infusion in hypertensive but not normotensive subjects.

Authors:  T J Tunny; R D Gordon; A W Bachmann; S A Klemm
Journal:  Clin Auton Res       Date:  1992-10       Impact factor: 4.435

8.  Effect of phorbol ester on the release of atrial natriuretic peptide from the hypertrophied rat myocardium.

Authors:  P Kinnunen; T Taskinen; M Järvinen; H Ruskoaho
Journal:  Br J Pharmacol       Date:  1991-02       Impact factor: 8.739

9.  Alterations in circulating vasoactive substances in the critically ill--a comparison between survivors and non-survivors.

Authors:  J Boldt; T Menges; D Kuhn; C Diridis; G Hempelmann
Journal:  Intensive Care Med       Date:  1995-03       Impact factor: 17.440

10.  Comparison of Plasma Levels of Renin, Vasopressin and Atrial Natriuretic Peptide in Hypertensive Amlodipine Induced Pedal Oedema, Non-Oedema and Cilnidipine Treated Patients.

Authors:  Kiran Shetty; Ranjan Shetty; Pragna Rao; Mamatha Ballal; Amruth Kiran; Sravan Reddy; Umesh Pai; Jyothi Samanth
Journal:  J Clin Diagn Res       Date:  2017-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.